Open AccessJournal Article
Establishment and characterization of a human prostatic carcinoma cell line (PC-3).
TLDR
The establishment, characterization, and tumorigenicity of a new epithelial cell line (PC-3) from a human prostatic adenocarcinoma metastatic to bone is reported, which should be useful in investigating the biochemical changes in advanced prostatic cancer cells and in assessing their response to chemotherapeutic agents.Abstract:
The establishment, characterization, and tumorigenicity of a new epithelial cell line (PC-3) from a human prostatic adenocarcinoma metastatic to bone is reported The cultured cells show anchorage-independent growth in both monolayers and in soft agar suspension and produce subcutaneous tumors in nude mice Culture of the transplanted tumor yielded a human cell line with characteristics identical to those used initially to produce the tumor PC-3 has a greatly reduced dependence upon serum for growth when compared to normal prostatic epithelial cells and does not respond to androgens, glucocorticoids, or epidermal or fibroblast gowth factors Karyotypic analysis by quinacrine banding revealed the cells to be completely aneuploid with a modal chromosome number in the hypotriploid range At least 10 distinctive marker chromosomes were identified The overall karyotype as well as the marker chromosomes are distinct from those of the HeLa cell Electron microscopic studies revealed many features common to neoplastic cells of epithelial origin including numerous microvilli, junctional complexes, abnormal nuclei and nucleoli, abnormal mitochondria, annulate lamellae, and lipoidal bodies Overall, the functional and morphologic characteristics of PC-3 are those of a poorly-differentiated adenocarcinoma These cells should be useful in investigating the biochemical changes in advanced prostatic cancer cells and in assessing their response to chemotherapeutic agentsread more
Citations
More filters
Journal ArticleDOI
Differential Inhibition of Invasion and Proliferation by Bisphosphonates: Anti-Metastatic Potential of Zoledronic Acid in Prostate Cancer
Richard J. Montague,Claire A Hart,N. J. R. George,Vijay A C Ramani,Michael D Brown,Noel W. Clarke +5 more
TL;DR: Zoledronic acid is a potent inhibitor of PEC invasion across bone marrow endothelium and colony formation with the bone marrow stroma, affecting the MMP: TIMP-2 balance to favour MMP inhibition.
Journal ArticleDOI
Tyrosine kinase inhibitor CEP-701 blocks the NTRK1/NGF receptor and limits the invasive capability of prostate cancer cells in vitro.
Claudio Festuccia,Paola Muzi,Giovanni Luca Gravina,Danilo Millimaggi,Silvia Speca,Vincenza Dolo,Enrico Ricevuto,Carlo Vicentini,Mauro Bologna +8 more
TL;DR: The malignancy of PCa seems to be accompanied by increased TrkA and TrkB signaling (with a reduction of p75 NGFR expression) and CEP-701 could be used to reduce the metastasis formation in advanced PCa.
Journal ArticleDOI
Development of innovative paclitaxel-loaded small PLGA nanoparticles: study of their antiproliferative activity and their molecular interactions on prostatic cancer cells.
D. Le Broc-Ryckewaert,Rodolphe Carpentier,Rodolphe Carpentier,Emmanuelle Lipka,S. Daher,Claude Vaccher,Didier Betbeder,Didier Betbeder,Didier Betbeder,Christophe Furman +9 more
TL;DR: This study suggests that both positively and negatively charged paclitaxel-loaded small PLGA nanoparticles deliver this drug into PC3 cells, and that this nanoparticle mode of delivery highly improves pac litaxel efficiency by up to two log-increase.
Journal Article
Production of monoclonal antibody alpha Pro3 recognizing a human prostatic carcinoma antigen.
TL;DR: Successful competition between alpha Pro3 and prostatic carcinoma patient serum immunoglobulin for a Mr 54,000 antigen (reduced molecular weight) present in prostate cancer tissue extract suggests that p54 may play a significant role in the immunobiology of prostatic cancer.
Journal ArticleDOI
Inhibition of growth and induction of apoptosis by androgens of a variant of LNCaP cell line.
Marie-Odile Joly-Pharaboz,Alain Ruffion,A.M. Roch,Laurence Michel-Calemard,J. André,J. André,Jacqueline Chantepie,B. Nicolas,Geneviève Panaye +8 more
TL;DR: It is demonstrated in culture but not in vivo, for the first time to the authors' knowledge, that a synthetic androgen is able to induce apoptosis of cells established from human prostate carcinoma.